Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-21 5:48 pm Sale | 2025-10-20 | 13D | Artelo Biosciences, Inc. ARTL | Farb Daniel Stuart | 16,399 0.800% | -136,604 (-89.28%) | Filing History |
| 2025-10-17 5:01 pm Unchanged | 2025-10-15 | 13D | Artelo Biosciences, Inc. ARTL | Farb Daniel Stuart | 153,003 7.700% | 0 (Unchanged) | Filing History |
| 2025-10-03 5:21 pm Purchase | 2025-10-01 | 13D | Artelo Biosciences, Inc. ARTL | Farb Daniel Stuart | 153,003 7.700% | 3 (+0.00%) | Filing History |
| 2025-09-19 11:58 am Purchase | 2025-09-12 | 13D | Artelo Biosciences, Inc. ARTL | Farb Daniel Stuart | 153,000 9.800% | 153,000 (New Position) | Filing History |
| 2022-02-23 4:36 pm Sale | 2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Iroquois Capital Management, LLC | 1,111 0.240% | -9,111 (-89.13%) | Filing History |
| 2022-02-09 11:08 am Sale | 2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Parian Global Management LP | 0 0.000% | -13,330 (Position Closed) | Filing History |
| 2022-02-04 3:19 pm Sale | 2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Hudson Bay Capital Management LP | 0 0.000% | -10,222 (Position Closed) | Filing History |
| 2021-03-01 4:38 pm Purchase | 2021-02-22 | 13G | Artelo Biosciences, Inc. ARTL | Parian Global Management LP | 13,330 7.640% | 13,330 (New Position) | Filing History |
| 2021-02-16 09:53 am Sale | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | CVI Investments, Inc. | 8,819 4.900% | -1,404 (-13.73%) | Filing History |
| 2021-02-10 4:12 pm Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | BIGGER CAPITAL FUND L P | 10,000 4.990% | 0 (Unchanged) | Filing History |
| 2021-02-08 5:07 pm Purchase | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Hudson Bay Capital Management LP | 10,222 5.740% | 10,222 (New Position) | Filing History |
| 2021-02-05 4:23 pm Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | KINGSBROOK PARTNERS LP | 8,889 4.990% | 0 (Unchanged) | Filing History |
| 2021-01-15 11:30 am Sale | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Alpha Capital Anstalt | 8,711 4.990% | -178 (-2.00%) | Filing History |
| 2021-01-13 09:02 am Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Empery Asset Management, LP | 10,222 4.990% | 0 (Unchanged) | Filing History |